WO2024062348 - HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC

National phase entry:
Publication Number WO/2024/062348
Publication Date 28.03.2024
International Application No. PCT/IB2023/059145
International Filing Date 14.09.2023
Title [English] HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC [French] COMPOSITIONS DE GEL MONOPHASE HYDROALCOOLIQUE POUR L'ADMINISTRATION TOPIQUE DE DICLOFÉNAC
Applicants ** HALEON CH SARL Route De L'Etraz 1197 Prangin, CH
Inventors ** KISAK, Ed c/o Tioga Research, Inc. 6330 Nancy Ridge Drive Suite 102 San Diego, California 92121, US LU, Guojin c/o HALEON 1211 Sherwood Avenue Richmond, Virginia 23220, US NEWSAM, John c/o Tioga Research, Inc. 6330 Nancy Ridge Drive Suite 102 San Diego, California 92121, US PATIL, Shantesh c/o HALEON 1211 Sherwood Avenue Richmond, Virginia 23220, US
Priority Data 22196979.3  21.09.2022  EP
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 996
EPO Filing, Examination 4843
Japan Filing 571
South Korea Filing 578
USA Filing, Examination 2635
MasterCard Visa
Total: 9623
The term for entry into the National Phase has expired. This quotation is for informational purposes only.

Abstract [English] Hydroalcoholic single phase gel compositions comprising diclofenac or a pharmaceutically acceptable salt of diclofenac are disclosed. The compositions are single phase compositions, and don't contain a lipophilic phase. The compositions can comprise at least one non-ionic surfactant. The compositions are useful in the topical delivery of diclofenac. The compositions can be used in the treatment of for example pain. [French] L'invention concerne des compositions de gel monophase hydroalcoolique comprenant du diclofénac ou un sel de diclofénac pharmaceutiquement acceptable. Les compositions sont des compositions monophases, et ne contiennent pas de phase lipophile. Les compositions peuvent comprendre au moins un tensioactif non ionique. Les compositions sont utiles dans l'administration topique de diclofénac. Les compositions peuvent notamment être utilisées dans le traitement de la douleur.